AMICUS THERAPEUTICS, INC. (Company) WILMINGTON TRUST, NATIONAL ASSOCIATION (Trustee) 3.00% Convertible Senior Notes due 2023 INDENTURE Dated as of December 21, 2016Amicus Therapeutics Inc • December 21st, 2016 • Pharmaceutical preparations • New York
INDENTURE, dated as December 21, 2016, between Amicus Therapeutics, Inc., a Delaware corporation, as issuer (the “Company”), and Wilmington Trust, National Association, a national banking association, as trustee (the “Trustee”).
NOTE PURCHASE AGREEMENTNote Purchase Agreement • December 21st, 2016 • Amicus Therapeutics Inc • Pharmaceutical preparations • Delaware
This NOTE PURCHASE AGREEMENT (this “Agreement”) is made as of the 15th day of December, 2016 by and among Redmile Capital Offshore Fund, Ltd. (the “Seller”), Amicus Therapeutics International Holding LTD (“Amicus International”) and Amicus Therapeutics, Inc. (the “Purchaser”).
NOTE PURCHASE AGREEMENTNote Purchase Agreement • December 21st, 2016 • Amicus Therapeutics Inc • Pharmaceutical preparations • Delaware
This NOTE PURCHASE AGREEMENT (this “Agreement”) is made as of the 15th day of December, 2016 by and among Redmile Capital Offshore Fund II, Ltd. (the “Seller”), Amicus Therapeutics International Holding LTD (“Amicus International”) and Amicus Therapeutics, Inc. (the “Purchaser”).
NOTE PURCHASE AGREEMENTNote Purchase Agreement • December 21st, 2016 • Amicus Therapeutics Inc • Pharmaceutical preparations • Delaware
This NOTE PURCHASE AGREEMENT (this “Agreement”) is made as of the 15th day of December, 2016 by and among GCM Grosvenor Special Opportunities Master Fund, Ltd. (the “Seller”), Amicus Therapeutics International Holding LTD (“Amicus International”) and Amicus Therapeutics, Inc. (the “Purchaser”).
